Clinical Trial Update: Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing nitazoxanide plus lactulose versus lactulose alone for hepatic encephalopathy. The status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• LACTULOSE (Lactulose)
• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Encephalopathy, Hepatic | Phase 2, Phase 3 | Status: UNKNOWN